Urine test could spot bladder cancer without a scope
NCT ID NCT04943380
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a urine test called Cxbladder can accurately detect bladder cancer in 682 people who had blood in their urine. The test's results were compared to the standard method, a camera exam of the bladder (cystoscopy). The goal was to see if the urine test could reliably identify who has cancer and who does not, potentially reducing the need for invasive procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATURIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bay Pines Veterans Affairs
Bay Pines, Florida, 33744-8200, United States
-
James A Haley Veterans' Hospital
Tampa, Florida, 33612-4745, United States
-
James J. Peters VAMC
New York, New York, 10468-3904, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29401, United States
-
Minneapolis VA Health Care System
Minneapolis, Minnesota, 55417, United States
-
NWIHCS-Omaha VA Medical Center
Omaha, Nebraska, 68105, United States
-
Oklahoma City VA Hospital
Oklahoma City, Oklahoma, 73104, United States
-
South Florida Veterans Affairs
Miami, Florida, 33125, United States
-
Veterans Medical Research Foundation
San Diego, California, 92161, United States
-
White River Junction VAMC
White River Junction, Vermont, 05009, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can a Two-Drug attack shrink Hard-to-Treat bladder tumors?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New biologic drug DBC-664 takes aim at Hard-to-Treat cancers
- New antibody aims to unlock immune attack on Hard-to-Treat cancers